Predictive validity of two process-of-care quality measures for residential substance use disorder treatment by unknown
Harris et al. Addict Sci Clin Pract  (2015) 10:22 
DOI 10.1186/s13722-015-0042-5
RESEARCH
Predictive validity of two process-of-care 
quality measures for residential substance use 
disorder treatment
Alex H. S. Harris*, Shalini Gupta, Thomas Bowe, Laura S. Ellerbe, Tyler E. Phelps, Anna D. Rubinsky, 
John W. Finney, Steven M. Asch, Keith Humphreys and Jodie Trafton
Abstract 
Background: In order to monitor and ultimately improve the quality of addiction treatment, professional societies, 
health care systems, and addiction treatment programs must establish clinical practice standards and then operation-
alize these standards into reliable, valid, and feasible quality measures. Before being implemented, quality measures 
should undergo tests of validity, including predictive validity. Predictive validity refers to the association between 
process-of-care quality measures and subsequent patient outcomes. This study evaluated the predictive validity of 
two process quality measures of residential substance use disorder (SUD) treatment.
Methods: Washington Circle (WC) Continuity of Care quality measure is the proportion of patients having an out-
patient SUD treatment encounter within 14 days after discharge from residential SUD treatment. The Early Discharge 
measure is the proportion of patients admitted to residential SUD treatment who discharged within 1 week of admis-
sion. The predictive validity of these process measures was evaluated in US Veterans Health Administration patients 
for whom utilization-based outcome and 2-year mortality data were available. Propensity score-weighted, mixed 
effects regression adjusted for pre-index imbalances between patients who did and did not meet the measures’ crite-
ria and clustering of patients within facilities.
Results: For the WC Continuity of Care measure, 76 % of 10,064 patients had a follow-up visit within 14 days of 
discharge. In propensity score-weighted models, patients who had a follow-up visit had a lower 2-year mortality rate 
[odds ratio (OR) = 0.77, p = 0.008], but no difference in subsequent detoxification episodes relative to patients with-
out a follow-up visit. For the Early Discharge measure, 9.6 % of 10,176 discharged early and had significantly higher 
2-year mortality (OR = 1.49, p < 0.001) and more subsequent detoxification episodes.
Conclusions: These two measures of residential SUD treatment quality have strong associations with 2-year mortal-
ity and the Early Discharge measure is also associated with more subsequent detoxification episodes. These results 
provide initial support for the predictive validity of residential SUD treatment quality measures and represent the first 
time that any SUD quality measure has been shown to predict subsequent mortality.
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Background
In order to monitor and ultimately improve the quality of 
addiction treatment, professional organizations, health 
care systems, and addiction treatment programs must 
establish clinical practice standards and then operational-
ize these standards into reliable, valid, and feasible quality 
measures. Quality measures can help define and moti-
vate guideline-congruent care, reveal gaps in the contin-
uum of care, identify poor performers to whom quality 
improvement efforts can be targeted, and may provide 
an empirically-justified basis for performance-based 
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incentive programs. However, these benefits can only 
be realized if quality measures are valid and avoid unin-
tended consequences, neither of which is a given [1, 2].
Improvement in clinically important outcomes is the 
most prominent goal of health care and therefore may 
seem like the only legitimate “gold standard” for meas-
uring treatment quality. But using outcomes alone as 
quality measures presents at least three difficulties. First, 
post-treatment outcome data are often expensive and 
logistically difficult to collect. Second, using outcomes 
directly as quality measures requires risk adjustments for 
casemix and making debatable assumptions regarding 
missing baseline and follow-up data [3]. Third, outcome 
data alone cannot indicate if treatment access is sufficient 
or what structural and process changes might be needed 
to improve outcomes. Therefore, identifying treatment 
structure, access, and process measures in administrative 
data that reliably predict long-term outcomes is often the 
best available quality assessment method.
Predictive validity refers to the association between 
antecedent quality indicators (e.g., structural, access, 
and process-of-care measures) and subsequent qual-
ity indicators, such as patient outcomes. Associations 
between process-of-care measures and outcomes can be 
driven by many factors, including the fidelity with which 
the process can be operationalized with available data 
[4], selection of an appropriate outcome, the temporal 
proximity of the outcome to the clinical process, limited 
power to detect small effects, and potential bias due to 
unmeasured confounding factors [5]. Therefore, care and 
humility are indicated when interpreting the results of 
predictive validity studies. Regardless, if the presumed 
association between a process-of-care quality measure 
and patient outcomes cannot be demonstrated, the meas-
ure’s validity should be considered suspect.
Formulating and implementing quality measures with-
out careful empirical validation exposes all stakeholders 
to many risks, including promoting poor or incomplete 
care, and diverting effort and attention from potentially 
more important activities. Measures are often speci-
fied and implemented before enough data and/or inter-
est accumulates to conduct validation studies. In diverse 
areas of medicine, even when careful validation is under-
taken, the expected associations between process-of-
care measures and outcomes are often absent or weaker 
than expected. Furthermore, when previously validated 
measures are put into use, particularly with incentives, 
changes in care or coding practices can lead to changes 
in predictive validity or other unintended consequences 
[6–10]. Addiction treatment quality measures have not 
been immune from these challenges [2, 11–15].
Residential addiction treatment programs are impor-
tant features of the continuum of care for patients 
with SUD. As an intensive, relatively costly setting for 
SUD treatment, these programs are usually reserved 
for patients who need high levels of support, supervi-
sion, and stabilization before transitioning to outpatient 
continuing care. Two process-of-care measures have 
been proposed to capture elements of residential addic-
tion program quality, one proposed by the Washington 
Circle and one by Rand and the Altarum Institute. The 
Washington Circle (WC) was a group of national experts 
that sought to improve the accessibility and effective-
ness of SUD treatment through the use of quality meas-
urement systems. One of the WC’s major activities was 
developing quality measures for SUD treatment for 
publicly-funded and commercially-insured systems of 
care. One WC measure focuses on outpatient continu-
ing care after residential treatment [16]. WC Continuity 
of Care is a dichotomous measure indicating whether or 
not a patient had an outpatient SUD treatment encoun-
ter within 14 days after discharge from residential treat-
ment. The measure is intended to assess the minimum 
necessary service to provide quality treatment, but not 
necessarily optimal or sufficient continuity of care after 
residential treatment.
Garner et  al. [17] evaluated the predictive validity of 
the WC Continuity of Care measure in a sample of 342 
adolescents in long-term residential addiction treatment 
who were randomly assigned at discharge to either stand-
ard continuing care or an assertive continuing care con-
dition. Overall, adolescent patients whose treatment met 
the WC Continuity of Care criterion were significantly 
more likely to have achieved recovery status (no alcohol 
or other drug use, abuse, or dependence symptoms while 
living in the community during the previous 30 days) at 
3 months (OR = 1.92, p < 0.05). However, the predictive 
validity of this measure has never been evaluated in adult 
patients or beyond 3 months.
The other quality measure pertaining to residen-
tial SUD treatment was developed by RAND and the 
Altarum Institute as part of a national evaluation of 
mental health services commissioned by the US Veter-
ans Health Administration (VHA). The measure taps the 
proportion of patients with SUD diagnoses admitted to 
residential SUD treatment who are discharged or self-
discharge within 1 week of admission (“Early Discharge”). 
Patients who discharge early from residential addiction 
treatment programs typically have poorer outcomes 
and are more likely to be readmitted [18]. However, the 
strength of evidence for these associations is modest 
and the predictive validity of the Early Discharge quality 
measure itself has never been evaluated.
Therefore, the purpose of this study was to examine 
the predictive validity of these two process-of-care qual-
ity measures in the VHA, a large integrated health care 
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system with extensive SUD treatment services. Because 
we lack data on more clinically detailed outcomes, such 
as improvements in symptoms and functioning, the pri-
mary outcomes in this study are 2-year mortality and 
patterns of utilization that might signify either successful 
stabilization in an outpatient setting or an escalation of 
symptoms requiring subsequent readmission or detoxifi-
cation. Specifically, we hypothesized that WC Continuity 
of Care would be positively associated with subsequent 
outpatient SUD and mental health treatment after the 
14-day post-discharge observation period and nega-
tively associated with subsequent SUD and psychiatric 
inpatient admissions, detoxification episodes, as well as 
2-year mortality. We hypothesized that these relation-
ships would be in the opposite direction for the Early 
Discharge measure. If evidence can be found for the pre-
dictive validity of these measures, they could be used for 
system monitoring and quality improvement purposes 
in VHA’s Mental Health Information System [19], or by 
other integrated health care systems.
Methods
Calculating the Continuity of Care measure
Using VHA’s National Patient Care Database, we identi-
fied all patients with an SUD diagnosis who discharged to 
the community from one of VHA’s 54 Substance Abuse 
Residential Rehabilitation Programs (SARRTPs; bed 
section codes: 27, 37, 85, 86, 88, 111) in fiscal year 2009 
(FY09). We then determined whether each patient had 
an outpatient SUD visit within 14 days of discharge. SUD 
outpatient visits were defined as a clinical encounter in 
an SUD or mental health clinic in which an SUD diagno-
sis was recorded. Patients who transferred from the SAR-
RTP to another residential setting were excluded from 
the denominator.
Calculating the Early Discharge measure
Using VHA’s National Patient Care Database, we identi-
fied all patients with an admission to one of VHA’s SAR-
RTPs in FY09 with a SUD diagnosis, and determined 
whether each patient was discharged from the program 
to the community within 7 days. Although the denomi-
nators for the two measures are different (patients with 
admissions vs. patients with discharges), the samples 
largely overlap.
Outcomes
We examined if each measure was associated with the 
following utilization-based outcomes in the 6  months 
after each patient either met or did not meet the meas-
ures’ criteria: Number of subsequent admissions to a 
SARRTP, number of admissions to other mental health 
residential or inpatient programs, number of outpatient 
encounters in SUD clinics, number of outpatient encoun-
ters in mental health clinics, and number of detoxifica-
tion episodes. We also examined the association of each 
measure with 2-year mortality as determined by the 
VHA Vital Status file.
Propensity score modeling
Estimation of process-outcome associations from obser-
vational data is difficult because exposure to the process 
of care is non-random and often confounded with patient 
or program characteristics. Propensity score methods are 
often used to adjust for confounding. Here, a propensity 
score is defined as the probability of meeting a perfor-
mance measure conditional on pre-treatment covariates. 
Several methods have been developed to calculate pro-
pensity scores. We used boosted regression to estimate 
each patient’s propensity score for meeting each process-
of-care measure. Boosted regression has been shown to 
produce models with less prediction error than other 
common methods [20]. One-year pre-index variables 
used in the propensity score models were age, gender, 
marital status (Y/N), race/ethnicity, co-morbid psychi-
atric diagnoses, traumatic brain injury, co-morbid medi-
cal diagnoses (e.g., diabetes, hepatitis C), homelessness, 
outpatient and residential SUD and mental health service 
utilization, and number of prior detoxification episodes.
Modeling associations between process measures 
and outcomes
For each process-of-care quality measure, using a pro-
pensity-score weighted [20], mixed-effects regression 
model, we evaluated if getting the measure-specified 
care (yes/no) was associated with patient-level outcomes 
beyond the possible effect of facility-level performance 
on the measure [21]. These models included VHA facil-
ity as a random effect and an exchangeable covariance 
structure. Utilization-based outcomes were modeled by 
mixed-effects, zero-inflated, negative binomial regres-
sion models. Two-year mortality was modeled in mixed-
effects logistic regression models.
Facility‑level variability
In order to assess the extent to which performance on 
these measures varied between facilities, we calculated 
descriptive statistics and histograms of the distributions 
of facility-level performance of the VHA facilities with 
residential SUD programs.
Results
For the WC Continuity of Care measure, 10,064 patients 
met the denominator criterion (i.e., discharged from a 
residential SUD treatment program in FY09) and 7648 
(76 %) met the numerator criterion by having a follow-up 
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visit within 14  days of discharge. The characteristics 
of patients who met versus did not meet the measure’s 
numerator criterion are presented in Table 1, along with 
the characteristics of the “failed to meet” sample after 
weighting with propensity scores. Even, before propen-
sity score weighting, the two groups were very similar on 
most characteristics. The most pronounced differences 
between patients meeting and not meeting the numera-
tor criterion were the number of SUD outpatient visits in 
the previous 6 months (15.4 vs. 9.8), homelessness in the 
previous year (30.1 vs. 26.7  %), and HIV positive status 
(1.8 vs. 2.6  %). All of these differences were reduced or 
eliminated by the weighting procedure.
In propensity score-weighted models, patients whose 
care met the WC Continuity of Care measure had sig-
nificantly more subsequent mental health admissions 
(b =  0.15, p =  0.015), significantly more mental health 
outpatient visits (b = 0.42, p < 0.001), and significantly 
more SUD outpatient visits (b  =  0.65, p  <  0.001). The 
measure was not significantly associated with number 
of subsequent admissions to residential SUD treatment 
programs or number of detoxification episodes. Nota-
bly, the odds of death in the two post-discharge years 
was significantly lower for patients who received the 
measure-specified continuity of care (4.35 vs. 5.57  %; 
OR =  0.77, p =  0.008). The unadjusted and propensity 
score-adjusted group differences in 2-year mortality and 
mean number of detoxifications in 6  months are pre-
sented in Table 2. Also, Fig. 1 shows substantial facility-
level variation (41–99 %) in the WC Continuity of Care 
measure.
For the Early Discharge measure, 10,176 patients met 
the denominator criterion (i.e., admitted to a residen-
tial SUD treatment program in FY09) and 974 (9.6  %) 
met the numerator criterion by experiencing discharge 
within 7  days. The characteristics of patients who met 
versus did not meet the measure’s numerator criterion 
are presented in Table  3, along with the characteristics 
of the “did not meet” sample after weighting with pro-
pensity scores. Unlike the WC Continuity of Care meas-
ure, it is considered undesirable to meet the numerator 
criterion for the Early Discharge measure. Again, even 
before propensity score weighting, the two groups were 
very similar on most characteristics. The most pro-
nounced differences between patients meeting and not 
meeting the numerator criterion were in the number of 
mental health outpatient visits in the previous 6 months 
(15.8 vs. 13.8), Caucasian race (66.8 vs. 59.3 %), traumatic 
brain injury (4.3 vs. 2.7 %), and HIV positive status (2.7 
vs. 1.8 %). All of these differences were reduced or elimi-
nated by the weighting procedure.
In propensity score-weighted models, patients who 
met the numerator criterion for early discharge had sig-
nificantly fewer mental health admissions (b  =  −0.65, 
p  <  0.001), mental health outpatient visits (b  =  −0.50, 
p < 0.001), SUD outpatient visits (b = −0.88, p < 0.001), 
and admissions to residential SUD treatment programs 
(b = −1.05, p < 0.001) in the following 6 months. Patients 
discharging early also had significantly more subsequent 
detoxification episodes (b = 0.11, p = 0.037). Finally, the 
odds of death in the two post-discharge years was sig-
nificantly higher in patients who discharged early and 
thereby met the numerator criterion (7.30 vs. 4.72  %; 
OR  =  1.49, p  <  0.001). The unadjusted and propensity 
score-adjusted group differences in 2-year mortality and 
mean number of detoxifications in 6  months are pre-
sented in Table 2. Also, Fig. 2 shows substantial facility-
level variation in this measure from 0 to 46 %.
Table 1 Demographic and  pre-index characteristics of  patients meeting and  not meeting the WC Continuity of  Care 
numerator criterion
Separate co-morbid medical diagnoses were included in the model but not presented in this table. No notable differences existed in these variables
Characteristic Met (N = 7648) Did not meet (N = 2416) Did not meet, weighted
Mean age (years) 49.1 49.8 49.1
Female 4.9 % 4.1 % 4.6 %
Caucasian 56.8 % 58.1 % 57.1 %
Married 21.8 % 22.2 % 22.0 %
Homeless in previous year 30.1 % 26.7 % 30.0 %
SUD outpatient visits 15.4 9.8 13.7
MH outpatient visits 14.5 12.0 13.0
Residential SUD admissions 0.07 0.08 0.07
Detoxification episodes 0.55 0.55 0.57
Co-morbid psychiatric diagnoses 80.1 % 80.0 % 80.7 %
Traumatic brain injury 2.9 % 2.6 % 2.6 %
HIV positive status 1.8 % 2.6 % 1.8 %
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Table 2 Unadjusted and adjusted outcomes in patients meeting and not meeting measure criteria
Adjustments refer to propensity score weighting in mixed effects regression models
Measure Outcome Patients meeting criteria Patients not meeting criteria
WC Continuity of Care Unadjusted 2-year mortality 4.50 % 5.92 %
Adjusted 2-year mortality 4.35 % 5.57 %
Unadjusted mean detoxes in 6 months 0.171 0.177
Adjusted mean detoxes in 6 months 0.175 0.185
Early Discharge Unadjusted 2-year mortality 7.30 % 4.72 %
Adjusted 2-year mortality 6.29 % 4.29 %
Unadjusted mean detoxes in 6 months 0.350 0.225
Adjusted mean detoxes in 6 months 0.240 0.215
Fig. 1 Distribution of facility performance on WC Continuity of Care
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Discussion
In this study, we examined the predictive validity of two 
process-of-care quality measures for residential SUD 
treatment in a large sample of patients in a very large 
integrated health care system. Ideally, data would have 
been available to examine the associations of these meas-
ures with near- and long-term changes in symptoms 
and functioning, instead of only administrative and uti-
lization data. We originally had hypotheses about the 
relationships between these measures and patterns of 
utilization, such as outpatient SUD treatment engage-
ment, that might signify successful stabilization, and pat-
terns of utilization, such as subsequent readmission or 
detoxification, that might signify an escalation. However, 
the results indicated that more utilization specified in 
the measures was generally associated with more subse-
quent utilization of both types. In other words, markers 
of engagement in the health care system are associated 
with other markers of later engagement in the health 
care system. In retrospect, this is unsurprising and con-
sistent with research in other clinical areas. The one type 
of utilization that ran counter to this general trend, how-
ever, was subsequent detoxification episodes. Although 
the WC Continuity of Care measure was unrelated to 
subsequent detoxification episodes, the Early Discharge 
measure (i.e., less initial utilization) was associated with 
significantly more subsequent detoxification episodes.
Even more impressive, both measures were associated 
with risk of death in the two post-discharge years in the 
expected directions: Continuity of Care with lower risk 
of death and Early Discharge with higher risk of death. 
These results are noteworthy given that mortality is a 
conceptually distal outcome of SUD treatment relative to, 
say, substance use. Previous efforts in the area of addic-
tion and more broadly to examine associations between 
continuity of care and retention quality measures and 
outcomes have largely found none (e.g., [22–24]) with 
some exceptions (e.g., [17, 25, 26]). However, this is the 
first study of addiction treatment process measures to 
find associations with risk of death. It is possible but 
unlikely that the associations between these meas-
ures and risk of death are directly causal. Perhaps more 
likely is that these processes facilitate or are proxies for 
different levels of engagement with the health care sys-
tem, which in turn affect mortality risk. Alternatively, 
these processes may be associated with unmeasured 
factors that are linked to mortality. In an event, finding 
SUD treatment process-of-care quality measures that 
are so strongly linked with subsequent risk of death is 
remarkable.
This study has several limitations. First, the VHA is a 
large integrated health care system serving US military 
Veterans. It is unknown to what extent these findings 
generalize to different health care systems or settings. 
Second, although patients who met the measures and 
patients who did not meet the measures were very simi-
lar on measured characteristics, and differences that did 
exist were trivial after propensity score weighting, these 
patients may have also differed on unmeasured charac-
teristics, such as SUD severity or travel time to care, that 
could affect outcomes.
With these caveats in mind, it is still noteworthy that 
these two process-of-care quality measures for residen-
tial SUD treatment are linked to 2-year mortality risk, 
and the Early Discharge measure was associated with 
subsequent detoxification episodes. These results provide 
important new evidence supporting the predictive valid-
ity of the WC Continuity of Care measure and the Early 
Discharge measure, and thereby, affirming their value as 
tools to monitor the quality of residential SUD care for 
Table 3 Demographic and pre-index characteristics of patients meeting and not meeting the Early Discharge numerator 
criterion
Separate co-morbid medical diagnoses were included in the model but not presented in this table. No notable differences existed in these variables
Characteristic Met (N = 974) Did not meet (N = 9202) Did not meet, weighted
Mean age (years) 49.2 49.4 49.1
Female 5.7 % 4.5 % 5.3 %
Caucasian 66.8 % 59.3 % 65.6 %
Married 24.3 % 22.1 % 23.8 %
Homeless in previous year 29.2 % 29.4 % 29.6 %
SUD outpatient visits 15.8 14.1 15.4
MH outpatient visits 15.8 13.8 15.5
Residential SUD admissions 0.09 0.07 0.08
Detoxification episodes 0.72 0.54 0.70
Co-morbid psychiatric diagnoses 85.0 % 80.7 % 84.5 %
Traumatic brain injury 4.3 % 2.7 % 4.0 %
HIV positive status 2.7 % 1.8 % 2.2 %
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adults. Because these results were not guaranteed, we 
believe our study shows the importance of subjecting 
quality measures to validity checks before implement-
ing them in clinical practice. Where these measures are 
implemented, especially if attached to incentives or con-
sequences for providers or systems of care, it is critical to 
make sure that they do not drive unintended changes in 
practice (e.g., instituting a cursory follow-up program to 
meet the measure) that will dilute or destroy the process-
outcome associations found in this study.
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